<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: If <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> plays a causal role in atherogenesis, individuals with proinflammatory gene variants would be expected to develop more <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We recently found a synergistic association between 3 functional proinflammatory gene polymorphisms/haplotypes and smoking on carotid intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>We replicated this finding in a second large population and extended the analysis by inclusion of other inflammatory conditions (<z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> and <z:hpo ids='HP_0001513'>obesity</z:hpo>/<z:hpo ids='HP_0001952'>abnormal glucose tolerance</z:hpo>) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Common carotid and femoral artery <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> was determined in the Bruneck Study population (n=810) </plain></SENT>
<SENT sid="4" pm="."><plain>Proinflammatory variants were determined in 3 genes (IL-6 [-174C, -572G, -597A haplotype], IL-1-receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> [VNTR *2], and endotoxin receptor CD-14 [-159C]) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: There was a significant relationship between gene-variant score and carotid <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>: age- and sex-adjusted mean <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> in subjects with 0, 1, and &gt;or=2 gene variants was 936, 987 and 1047 microm, respectively (P=0.001), and synergistic effects of gene-variant score and smoking on <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> measurements (P=0.040) </plain></SENT>
<SENT sid="6" pm="."><plain>Analogous findings were obtained for <z:hpo ids='HP_0001513'>obesity</z:hpo>/<z:hpo ids='HP_0001952'>abnormal glucose tolerance</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Interactive effects of gene-variant score and a risk factor score composed of the acquired inflammatory conditions were highly significant (P&lt;0.001 each) </plain></SENT>
<SENT sid="8" pm="."><plain>Results were similar for femoral artery <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: These results provide support for a causal role of <z:mp ids='MP_0001845'>inflammation</z:mp> in carotid <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, and emphasize the importance of gene-gene and gene-environment interactions in this pathogenic pathway </plain></SENT>
<SENT sid="10" pm="."><plain>This may help to explain the substantial variability of disease expression in subjects with proinflammatory risk factors such as smoking, <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
</text></document>